JAMI DODSON: Open Payments
NPI 1942559331 · CORPUS CHRISTI, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$296 in 12 payments from 9 companies in 2025. Trend: 2023 $746 · 2024 $435 · 2025 $296
Food & beverage: $296
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 3 | $125 |
| Novo Nordisk Inc | 2 | $45 |
| Corcept Therapeutics | 1 | $20 |
| Sumitomo Pharma America, Inc. | 1 | $19 |
| Lilly USA, LLC | 1 | $19 |
| Exact Sciences Corporation | 1 | $18 |
| IDORSIA PHARMACEUTICALS US INC | 1 | $18 |
| SHIELD THERAPEUTICS INC | 1 | $17 |
| Amgen Inc. | 1 | $15 |
Products named: LEQVIO, Wegovy, Korlym, GEMTESA, MOUNJARO, Cologuard Collection Kit, Quviviq, ACCRUFER.
Industry payments across TX — which companies pay providers there.
